title: [New opportunities to treat combined luts in patients with benign prostatic hyperplasia premises and advantages].
abstract: This paper provides an overview of studies on the prevalence, pathogenesis and management of combined lower urinary tract symptoms (LUTs) in men. The authors emphasize the role of urodynamic studies in the diagnosis of LUTs in the pre- and postoperative period aimed at the early detection of functional lower urinary tract disorders and selection of the appropriate medical treatment.
authors.affiliation: I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.
authors.forename: Z K
authors.initials: ZK
authors.lastname: Gadzhieva
authors.affiliation: I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.
authors.forename: Yu B
authors.initials: YB
authors.lastname: Kazilov
mesh_terms: D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000601:surgery; D014563:Urodynamics
chemical_list: D004338:Drug Combinations; D018727:Muscarinic Antagonists
keywords: 1-blockers; 3-adrenoagonists; M-cholinoblockers; benign prostatic hyperplasia; combination therapy; lower urinary tract symptoms; mirabegron; prevalence; vesomni